Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
The dual roles of NRF2 in cancer
Molecular and Structural Insights Sturmlechner, I., et al
GLP1 medications help improve insulin sensitivity and glucose utilization, reducing the tendency for excess glucose to be stored as fat while providing more stable energy levels throughout the day
US$ 20.70
US$ 22.46
US$ 29.73
US$ 28.59
US$ 20.14
